Somatic mutations in BRCA2, NFE2L2, ARID1A and NOTCH1 sensitize to anti-PDL1 therapy in multiple tumor types
- Resource Type
- Source
- Annals of Oncology. 29:x1
- Subject
0301 basic medicine ARID1A Somatic cell business.industry Hematology NFE2L2 03 medical and health sciences 030104 developmental biology 0302 clinical medicine Oncology 030220 oncology & carcinogenesis Cancer research Medicine Multiple tumors business - Language
- ISSN
- 0923-7534